The MAPH Score Predicts Coronary Slow Flow. A Retrospective Case-Controlled Study

Mustafa Kaplangoray1, Kenan Toprak2, Cihan Aydın3

  • 1Bilecik Şeyh Edebali University, Faculty of Medicine.

Kardiologiia
|March 11, 2024
PubMed

Insights

The new MAPH score, combining mean platelet volume, hematocrit, and total protein, effectively identifies coronary slow flow phenomenon (CSF). This score shows better predictive performance than individual markers for diagnosing CSF.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Clinical Diagnostics

Background:

  • Coronary slow flow phenomenon (CSF) is a condition affecting coronary blood flow.
  • Whole blood viscosity (WBV) markers like mean platelet volume (MPV), hematocrit, and total protein are implicated in cardiovascular health.
  • A novel score integrating these WBV markers could improve CSF diagnosis.

Purpose of the Study:

  • To develop and validate the MAPH score, integrating MPV, hematocrit, and total protein.
  • To investigate the association between the MAPH score and the presence of CSF.
  • To compare the diagnostic performance of the MAPH score against individual markers for CSF.

Main Methods:

  • A study cohort of 201 patients was analyzed, with 105 diagnosed with CSF and 96 with normal coronary flow (NCF).
  • Coronary flow was assessed using the Thrombolysis in Myocardial Infarction frame count (TFC) method.
  • The MAPH score was calculated based on cut-off values for MPV, hematocrit, and total protein, determined via Youden's index.

Main Results:

  • The CSF group exhibited significantly higher levels of total protein, MPV, hematocrit, and calculated shear rates (HSR, LSR) compared to the NCF group.
  • Receiver operating characteristic (ROC) curve analysis demonstrated that the MAPH score significantly outperformed individual parameters in predicting CSF.
  • The MAPH score showed superior performance in identifying patients with CSF.

Conclusions:

  • The MAPH score is a novel and effective tool for identifying the presence of coronary slow flow phenomenon (CSF).
  • This integrated score offers improved diagnostic capability compared to assessing individual WBV markers.
  • The MAPH score holds potential for clinical application in the diagnosis of CSF.
Abstract